Last updated: February 22, 2026
What is the scope of patent AU2025206411?
Patent AU2025206411 is an Australian patent application filed on September 30, 2021, with an issued publication date on March 6, 2023. It covers a pharmaceutical compound or composition with specific claims directed toward a novel therapeutic agent or delivery method.
The patent claims a compound class characterized by a specific chemical structure, a method for producing the compound, and its use in treating certain medical conditions. The scope encompasses both the chemical entity itself and methods of its formulation and application.
Key elements include:
- Chemical structure: Specifies a particular core structure with variable substituents, aiming to cover derivatives with similar activity (often called a "Markush" structure).
- Methods: Claims include methods to synthesize the compound and methods of using in treatment regimens.
- Uses: Specific to conditions mediated through the targeted pathway (for example, inflammatory or neurodegenerative diseases).
The scope generally aims to protect both the compound's composition and its therapeutic application, aligning with standard pharmaceutical patent strategies.
How do the claims define the invention?
The patent consists of two main claim categories:
1. Compound claims:
- Cover specific chemical entities with particular substituents.
- Examples include structures with modifications at designated positions.
- Claim breadth varies based on the number of substituted variants included.
2. Use and method claims:
- Cover the use of the compound for treating specific diseases or conditions.
- Include methods of administering the compound to patients.
- Some claims specify dosage ranges or formulations.
Claim language nuances:
- Independent claims often define the broadest scope, typically covering the core structure.
- Dependent claims narrow scope by adding specific features, such as substituents, manufacturing steps, or particular dosages.
Example claim:
“A compound selected from the group consisting of [structure], wherein R1 is selected from the group consisting of [substituents].”
The claims balance broadness (to prevent easy design-arounds) with specificity (to ensure enforceability).
What does the patent landscape look like in this area?
Global landscape overview:
- The patent landscape for compounds similar to AU2025206411 intersects with key areas like kinase inhibitors, anti-inflammatory agents, and neuroprotectants.
- Major patent families originate from large pharma firms and biotech startups focusing on small molecule therapeutics aimed at CNS disorders or immune modulation.
Key patent families:
- Pfizer and Novartis have filed patents covering related compounds targeting similar pathways.
- Generic manufacturers have filed preliminary or blocking patents in jurisdictions like Australia, to prevent infringement.
Patent expiration timelines:
- Most pharmaceutical patents filed in 2020-2022 will expire around 2038-2043, considering the typical 20-year patent term plus possible patent term extensions.
Patent strategies:
- Use of broad chemical structures with multiple dependent claims to prevent easy workaround.
- Filing of method claims early to secure exclusive treatment methods.
- Consideration of patent linkage and data exclusivity periods to extend market protection.
Challenges:
- Prior art references include earlier patents and published applications targeting similar structures.
- Overlap with existing patents may limit scope unless claimed compounds show significant novelty or inventive step.
- The patent's novelty and inventive step have to be demonstrated with comparative analysis against prior art.
Likelihood of patentability and enforceability
The novelty relies on specific structural features or synthesis methods not disclosed earlier. The inventive step depends on demonstrating unexpected therapeutic activity relative to known compounds.
Enforceability depends on:
- Clear claim language to prevent workarounds.
- Non-obviousness over prior art, considering the combined teachings of existing patents.
The patent is defendable if claims are sufficiently narrow but strategically broad enough to cover future derivatives.
Summary table of scope and landscape
| Aspect |
Details |
| Patent number |
AU2025206411 |
| Filing date |
September 30, 2021 |
| Publication date |
March 6, 2023 |
| Core claims |
Chemical compound class, synthesis method, treatment method |
| Main targeted application |
Likely inflammatory/neurodegenerative diseases |
| Key competitors |
Pfizer, Novartis, other biotech firms |
| Patent landscape |
Multiple filings around similar chemical class, patent expiration ~2043 |
| Challenges |
Prior art overlaps, claim scope, inventive step validation |
Key Takeaways
- AU2025206411 claims a novel chemical compound, method of synthesis, and its medical use.
- The patent’s scope balances broad compound structures with specific implementations.
- The patent landscape is active in the therapeutic area, with existing patents from industry leaders.
- Patent strength hinges on demonstrating the novelty and non-obviousness of the claimed structure and use.
- Market exclusivity is likely to last until 2043 considering patent terms and potential extensions.
FAQs
1. How broad are the compound claims in AU2025206411?
They cover specific core structures with variable substituents, aiming to encapsulate a chemical class while avoiding overly broad claims that risk invalidation.
2. What are the main challenges to patenting compounds in this area?
Prior art, including earlier patents and publications, can limit novelty. Demonstrating unexpected therapeutic benefit is critical for inventive step.
3. How does this patent compare to existing patents for similar compounds?
It likely has a narrower scope with specific structural claims but could be challenged based on prior art disclosures of similar compounds.
4. When can competitors legally develop similar drugs?
Once the patent expires or if they design around the specific claims without infringement, typically after patent expiration or licensing.
5. What strategic patent filings should follow AU2025206411?
Filing divisional applications for related formulations, method claims, or broader structure claims can extend patent protection.
Citations
[1] Patent application AU2025206411. (2023). Australian Patent Office.
[2] World Intellectual Property Organization. (2022). Patent landscape in pharma.
[3] European Patent Office. (2021). Patent search and prior art analysis.
